FundRx InsightsHow to Fix Drug PricesMake Europe and other developed nations pay their fair share for American innovation.Jan 6, 2016Jan 6, 2016
FundRx InsightsImproving ObamaCare — The Subsidies IssueThis is the first in a series of articles on improving the Affordable Care Act (ACA). As I’ve argued before, Obamacare is here to stay —…Dec 21, 2015Dec 21, 2015
FundRx InsightsHedging against the drug resistant futureWhen the United Nations Climate Change Conference kicks off in Paris this Monday, we can expect to hear a lot about the future, about our…Nov 29, 2015Nov 29, 2015
FundRx InsightsHow to Rig Your Next Clinical Trial — and Why FundRx Will Catch YouWith thousands of hours and millions of dollars at stake, early-stage healthcare companies live and die by the results of clinical trials…Nov 29, 2015Nov 29, 2015
FundRx Insights2016 Election — Little Impact on Healthcare EconomyIn the wake of last Friday’s horrifying attacks on Paris and as rhetoric turns increasingly nativist on the question of refugees, we’re in…Nov 23, 2015Nov 23, 2015
FundRx InsightsObamacare — a boon for the economyMarkets represent the judgment of buyers and sellers of what’s valuable.Nov 11, 2015Nov 11, 2015
FundRx InsightsShould we peer-review Theranos?There are many questions for Ms. Holmes and Theranos (original WSJ story and Theranos response). But the biggest question, still…Nov 2, 2015Nov 2, 2015
FundRx InsightsObama’s Trade Deal and Drug Patents: A Painful, Necessary CompromiseLike any good compromise, everyone is a little bit dissatisfied.Oct 17, 2015Oct 17, 2015
FundRx InsightsDrug Pricing Controversy: Physicians Have More Power Than They ThinkBy hiking the price of a Daraprim tablet from $13.50 to $750 overnight, Turing Pharmaceuticals generated a fascinating controversy around…Oct 2, 20151Oct 2, 20151
